πŸ“˜ New 2nd Edition: FDA & IP Strategies for Medical Device Innovators
Banner Image

A REGULATORY PATHMAKER FOR EMERGING BIOTECH

Create a viable route toward FDA and market acceptance with Facet – the regulatory affairs and product development strategy partner for small biotech and emerging science.

LET'S TALK ABOUT YOUR PATH
Decorative polygon

Transforming Scientific Innovation into Regulatory Readiness

Facet Life Sciences helps small life science companies navigate drug, biologic, and medical device development with precision and expertise. We specialize in charting entrepreneurial, successful FDA regulatory pathways for novel and complex innovations. We guide you to and through the FDA, so you can get your products to patients in need.

Custom Solutions for Every Stage of Product Development

With decades of experience in product development, nonclinical, clinical, CMC, regulatory affairs, and commercial launch, our experts are ready to support your unique goals and lead every stage of your process from early regulatory planning to meeting preparation and submission leadership.

Ensure your evidence is clear, your rationale is defensible, and your interactions with the FDA are well-reasoned and productive.

Where Are You On Your Journey?

For over a decade, Facet has been helping organizations reach successful FDA and commercial outcomes.


Discovery

PRE-IND/
Q-Sub
MTG

Clinical
Research

Launch/
Marketing

Preclinical
Research

IND/
IDE

Marketing
Application

Expert Regulatory Solutions

Regulatory Services

Aggressive, scientifically sound progress to development and regulatory milestones. Strategies aligned with your resources and business objectives.

Medical Writing

Clear, concise, and accurate presentation of nonclinical, CMC, and clinical data, written with the FDA reviewer in mind.

Strategic Statistical Services

Using biometrics to develop lean and efficient nonclinical and clinical trial designs. Improve effectiveness and increase the probabilities of success.

Asset Valuation and Optimization

Understand your asset value and learn how to improve it through your R&D efforts. Translate your science into product value and answers to investor or partner questions.

Bring Complex Innovations to Market With Full-Lifecycle Regulatory Support

At Facet, we know how FDA reviewers interpret data, how decisions are made, and how to prepare submissions that withstand scrutiny.

We also know that traditional development models built for large pharma and major CROs often don’t fit the needs of today’s nimble emerging companies.

That’s why we develop strategies tailored to your product, resources, and goals β€” and execute them alongside you and our partners, step by step, as a true extension of your team.

Regulatory Services

Hundreds of years of combined experience working directly with FDA to ensure your interactions are productive and submissions are thorough, well-prepared, and on target.

R&D and Asset Valuation Strategies

We develop customized regulatory, statistics, and asset value strategies to accelerate your plans and maximize your success.

Broad Therapeutic Experience

Our knowledge spans all therapeutic areas and most dosage forms, providing comprehensive support.

WHY CHOOSE FACET LIFE SCIENCES?

Your Regulatory Success Is Our Mission

At Facet, your success drives us. We form lasting partnerships, offering the expertise and tools needed to bring your product to divestiture or market successfully. Join the many companies that have turned their innovative ideas into reality with Facet Life Sciences.

Client Success Stories

Previous

"Facet proactively worked with us and FDA to design and implement a Phase 3 program that was manageable for a small company to conduct. Facet was a critical part of our NDA application strategy and used their expertise to author, finalize, submit, and shepherd our combination product NDA through the FDA review process."

Ken West, Board Member and Former CEO

"Facet's innovative strategies got us to an open IND faster than we expected. What's more, their dynamic approach and excellent working relationship with the FDA has us well positioned to progress our unique disease-modifying therapy."

Marc Gleeson, Small Pharma CEO

"Facet helped our team achieve something unheard of in the psychedelics industry. Their strategic leadership and flawless tactical execution supported us from conception to successful IND-filing for a new chemical entity in 18 months."

Michael Palfreyman, Ph.D, Industry Expert and Investor

"Facet took us from pivotal study database lock to NDA (approved) in six weeks."

Small Pharma CEO

Next

Awards & Recognition

great place to work certified badge for may 2023 to may 2024 USAtop regulatory services provider 2023 award awarded to facet life sciences by life sciences review.great place to work certified badge for april 2024 to april 2025 USAtop regulatory services provider 2024 award awarded to facet life sciences by life sciences reviewtop regulatory services provider 2025 award awarded to facet life sciences by life sciences review

Let’s Maximize Your Submission Window

Your company and your product deserve a strategic regulatory partner. Contact Facet Life Sciences to learn how we can help you reach your goals.

LEARN MORE ABOUT OUR UNIQUE APPROACH
Go to Top